REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 151 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $30,140,000 | +19.5% | 1,545,630 | 0.0% | 0.01% | +40.0% |
Q4 2021 | $25,225,000 | -41.4% | 1,545,630 | 0.0% | 0.01% | -50.0% |
Q3 2021 | $43,061,000 | -6.0% | 1,545,630 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $45,812,000 | +6.0% | 1,545,630 | 0.0% | 0.01% | -9.1% |
Q1 2021 | $43,200,000 | +31.2% | 1,545,630 | +33.0% | 0.01% | +22.2% |
Q4 2020 | $32,928,000 | +12.7% | 1,161,900 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $29,210,000 | +2.9% | 1,161,900 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $28,374,000 | +65.0% | 1,161,900 | 0.0% | 0.01% | +28.6% |
Q1 2020 | $17,196,000 | -8.8% | 1,161,900 | 0.0% | 0.01% | +16.7% |
Q4 2019 | $18,858,000 | +346.3% | 1,161,900 | +257.5% | 0.01% | +200.0% |
Q3 2019 | $4,225,000 | +0.2% | 325,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $4,215,000 | -17.7% | 325,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $5,122,000 | -21.7% | 325,000 | 0.0% | 0.00% | -33.3% |
Q4 2018 | $6,542,000 | -19.0% | 325,000 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $8,076,000 | – | 325,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |